ET1402L1-ARTEMIS ™2 T Cells in AFP Expressing Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma; Liver Cancer; Liver Neoplasms; Metastatic Liver Cancer Interventions: Biological: ET1402L1-ARTEMIS™ T cells -IV; Biological: ET1402L1-ARTEMIS™ T cells -intra-hepatic artery; Biological: ET1402L1-ARTEMIS™ T cells -Intratumoral Injections Sponsors: First Affiliated Hospital Xi'an Jiaotong University; Eureka Therapeutics Inc.; Aeon Therapeutics (Shanghai) Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver Cancer | Research